Afentra PLC
F:TB8A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Afentra PLC
F:TB8A
|
UK |
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
Wall St Price Targets
TB8A Price Targets Summary
Afentra PLC
According to Wall Street analysts, the average 1-year price target for TB8A is 0.92 EUR with a low forecast of 0.76 EUR and a high forecast of 1.05 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TB8A's stock price target?
Price Target
0.92
EUR
According to Wall Street analysts, the average 1-year price target for TB8A is 0.92 EUR with a low forecast of 0.76 EUR and a high forecast of 1.05 EUR.
What is the Revenue forecast for Afentra PLC?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 4 years is 10%.
What is the Gross Profit forecast for Afentra PLC?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 23%.
What is the Operating Income forecast for Afentra PLC?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 4 years is 15%.
What is the Pre-Tax Income forecast for Afentra PLC?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for Afentra PLC?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 22%.
